Title: Preliminary studies on the effect of 2,6-diaminopurine on transplanted mouse leukemia
Abstract: CancerVolume 2, Issue 1 p. 119-120 ArticleFree Access Preliminary studies on the effect of 2,6-diaminopurine on transplanted mouse leukemia Joseph H. Burchenal M.D., Joseph H. Burchenal M.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y. Fellow of the American Cancer Society, recommended by the Committee on Growth of the National Research Council.Search for more papers by this authorAaron Bendich PH.D., Aaron Bendich PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGeorge B. Brown PH.D., George B. Brown PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGertrude B. Elion M.S., Gertrude B. Elion M.S. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGeorge H. Hitchings PH.D., George H. Hitchings PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorC. P. Rhoads M.D., C. P. Rhoads M.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorC. Chester Stock PH.D, C. Chester Stock PH.D Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this author Joseph H. Burchenal M.D., Joseph H. Burchenal M.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y. Fellow of the American Cancer Society, recommended by the Committee on Growth of the National Research Council.Search for more papers by this authorAaron Bendich PH.D., Aaron Bendich PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGeorge B. Brown PH.D., George B. Brown PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGertrude B. Elion M.S., Gertrude B. Elion M.S. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorGeorge H. Hitchings PH.D., George H. Hitchings PH.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorC. P. Rhoads M.D., C. P. Rhoads M.D. Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this authorC. Chester Stock PH.D, C. Chester Stock PH.D Section on Mouse Leukemia of the Division of Experimental Chemotherapy, of the Sloan-Kettering Institute for Cancer Research, New York, N. Y., and the Wellcome Research Laboratories, Tuckahoe, N. Y.Search for more papers by this author First published: January 1949 https://doi.org/10.1002/1097-0142(194901)2:1<119::AID-CNCR2820020111>3.0.CO;2-UCitations: 66 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Bendich, A., and Brown, G. B.: 2,6-Diaminopurine a precursor of nucleic acid guanine. J. Biol. Chem. In press. 2 Bendich, A.; Tinker, J. F., and Brown, G. B.: A synthesis of isoguanine labeled with isotopic nitrogen. J. Am. Chem. Soc. 70: 3109–3113, 1948. 3 Burchenal, J. H.; Burchenal, J. R.; Kushida, M.; Johnston, S., and Williams, B. S.: Studies on the chemotherapy of leukemia. II. The effect of 4-amino-pteroylglutamic acïd and 4-amino-N10-methyl-pteroylglutamic acid on transplanted mouse leukemia. Cancer 2: 113–118, 1949. 4 Burchenal, J. H.; Burchenal, J. R.; Kushida, M.; Johnston, S., and Williams, B. S.: Studies on the chemotherapy of leukemia. IV. The effect of 2,6-diaminopurine on transmitted mouse leukemia. To be published. 5 Hitchings, G. H.; Elion, G. B.; Vander-Werff, H., and Falco, E. A.: Pyrimidine derivatives as antagonists of pteroylglutamic acid. J. Biol. Chem. 174: 765–766, 1948. Citing Literature Volume2, Issue1January 1949Pages 119-120 ReferencesRelatedInformation